| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.84M | 26.51M | 19.40M | 17.31M | 12.05M | 10.35M |
| Gross Profit | 28.58M | 21.43M | 10.71M | 6.04M | 3.07M | 2.65M |
| EBITDA | 14.16M | 6.16M | 2.93M | -1.25M | -1.23M | -1.74M |
| Net Income | 12.50M | 3.75M | -3.29M | -6.10M | -4.92M | -5.35M |
Balance Sheet | ||||||
| Total Assets | 65.75M | 65.87M | 70.19M | 63.88M | 67.42M | 70.16M |
| Cash, Cash Equivalents and Short-Term Investments | 1.25M | 1.70M | 466.00K | 1.10M | 5.08M | 15.60M |
| Total Debt | 7.81M | 4.05M | 12.29M | 13.38M | 11.00M | 12.86M |
| Total Liabilities | 8.87M | 13.69M | 20.84M | 22.35M | 19.99M | 20.10M |
| Stockholders Equity | 56.88M | 52.18M | 49.35M | 41.52M | 47.44M | 50.05M |
Cash Flow | ||||||
| Free Cash Flow | 17.12M | 15.71M | -7.84M | -5.78M | -10.29M | -7.69M |
| Operating Cash Flow | 17.46M | 15.90M | -2.80M | -504.00K | -3.84M | -1.62M |
| Investing Cash Flow | -4.80M | -4.55M | -5.00M | -5.27M | -6.45M | -6.07M |
| Financing Cash Flow | -10.54M | -9.19M | 7.18M | 1.99M | -1.23M | 14.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £534.43M | 10.73 | 8.34% | 2.09% | 0.49% | 61.73% | |
73 Outperform | £65.18M | 3.57 | 22.93% | ― | 36.61% | ― | |
69 Neutral | £283.07M | 31.22 | 12.26% | 1.89% | 5.46% | -26.44% | |
67 Neutral | £208.56M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £213.67M | -4.02 | -31.21% | ― | -16.33% | -448.12% | |
39 Underperform | £27.57M | -21.06 | -12.60% | ― | -14.81% | -1362.50% |